C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies

Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
12/2004
12/29/2004	CN1182399C Removal of prions from blood, plasma and other liquids
12/29/2004	CN1182244C Method of cell cultivation
12/29/2004	CA2530214A1 Cancerous disease modifying antibodies
12/29/2004	CA2529045A1 Monitoring immunologic, hematologic and inflammatory diseases
12/29/2004	CA2528599A1 Proton-sensing g-protein coupled receptors and dna sequences thereof
12/29/2004	CA2526647A1 Anti alpha - folate - receptor - tetramer antibodies
12/29/2004	CA2526640A1 Immunogenic reagents from west nile virus
12/29/2004	CA2525379A1 Compositions and methods for enhanced expression of immunoglobulins from a single vector using a peptide cleavage site
12/29/2004	CA2524567A1 Compositions and methods for the diagnosis and treatment of tumors of glial origin
12/28/2004	US6835824 Peanut allergens and methods
12/28/2004	US6835823 Anti-TNF antibodies and peptides of human tumor necrosis factor
12/28/2004	US6835822 Diagnosis and therapy of cancer using SGP28-related molecules
12/28/2004	US6835817 Monoclonal antibody which is specific for activated coagulation factor VII, and its use
12/28/2004	US6835816 Mammalian tumor susceptibility genes and their uses
12/28/2004	US6835715 Mammalian dihydroouabain-like factor and therapeutic compositions
12/28/2004	US6835546 Drosophila G protein coupled receptors, nucleic acids, and methods related to the same
12/28/2004	US6835384 Nucleic acids and polypeptides specific of the neisseria genus pathogenic strains
12/28/2004	US6835379 Removal of albumin resulting in an IgG fraction; purifying IgG from an IgG fraction, concentrating the IgG fraction; adjusting pH; carrying out the virus inactivation by using chemicals
12/28/2004	US6835370 Diagnosis and treatment of malignant neoplasms
12/28/2004	CA2072874C Polypeptides having human dopaminergic receptor activity, nucleic acids coding for said polypeptides and uses thereof for screening active substances on said polypeptides
12/26/2004	CA2458893A1 Treatment of chronic human viral hepatitis
12/26/2004	CA2430835A1 Methods for making and breaking prions (prpsc) produced from native prions (prpc), in vitro and from recombinant prion proteins
12/23/2004	WO2004111653A1 Assessment of skeletal growth using measurements of nt-cnp peptides
12/23/2004	WO2004111652A1 Use of prion conversion modulating agents
12/23/2004	WO2004111608A2 Method of altering the binding specificity of plasma proteins by oxidation-reduction reactions
12/23/2004	WO2004111233A1 Process for producing antibody
12/23/2004	WO2004111194A2 Method to increase protein production in culture
12/23/2004	WO2004111081A2 Antigenic peptides of sars coronavirus and uses thereof
12/23/2004	WO2004110487A1 Treatment of t cell mediated diseases by inhibition of fgfr3
12/23/2004	WO2004110486A1 Functionally reconstituted viral membranes containing adjuvant
12/23/2004	WO2004110390A2 Anti-cd74 immunoconjugates and methods
12/23/2004	WO2004110369A2 Cell surface protein associated with human chronic lymphocytic leukemia
12/23/2004	WO2004110363A2 Method of inhibiting tumor growth with anti-tissue factor antibodies
12/23/2004	WO2004110362A2 Immunotherapeutics for biodefense
12/23/2004	WO2004110355A2 Compositions and methods including a recombinant human mab that promotes cns remyelination
12/23/2004	WO2004110345A2 Differentially expressed genes involved in cancer, the polypeptides encoded thereby, and methods of using the same
12/23/2004	WO2004110139A1 Process for producing human-origin immunocompetent cell
12/23/2004	WO2004094673A8 Methods for monitoring drug activities in vivo
12/23/2004	WO2004087759A3 Method and compositions for conversion of antibody activity
12/23/2004	WO2004085474A3 Method of producing an antibody to epidermal growth factor receptor
12/23/2004	WO2004084943A8 Use of antagonists of ghrelin or ghrelin receptor to treat intestinal inflammation
12/23/2004	WO2004076684A3 Compositions and methods for the detection of mammalian muscle troponin i
12/23/2004	WO2004076620A3 Human antibodies specific for interleukin 15 (il-15)
12/23/2004	WO2004074310A8 Mycobacterial diagnostics
12/23/2004	WO2004072263A3 Nucleic acid and corresponding protein named 158p1d7 useful in the treatment and detection of bladder and other cancers
12/23/2004	WO2004067706A3 Production of multimeric proteins
12/23/2004	WO2004049917A3 Methods of therapy and diagnosis using targeting of cells that express ly-9
12/23/2004	WO2004046192A3 Method for isolating intracellular antibodies able to neutralize protein interactions
12/23/2004	WO2004007685A3 Methods of modifying behavior of cd9-expressing cells
12/23/2004	WO2003106692A3 Methods for the identification of all-antigens and their use for cancer therapy and transplantation
12/23/2004	WO2003101497A8 Knockout mice and their use
12/23/2004	WO2003076569A3 Novel polypeptides having sequence similarity to gdnfr and nucleic acids encoding the same
12/23/2004	WO2003050236A3 Human genes and gene expression products isolated from human prostate
12/23/2004	WO2002074240A3 Anti-amyloid antibody based diagnosis and treatment of a neurological disease or disorder
12/23/2004	US20040261148 Monoclonal antibodies with effector function; signal sequences
12/23/2004	US20040260070 Method and apparatus for detecting conception in animals
12/23/2004	US20040260069 Modified anti-tnf aplha antibody
12/23/2004	US20040260068 Humanized chicken antibodies
12/23/2004	US20040260067 Chimpanzee monoclonal antibodies and antigen binding fragments including complementary determining regions; drug screening; host cells; kits
12/23/2004	US20040260066 Method for purifying mixtures of immunoglobulin & albumin
12/23/2004	US20040259822 Antibody which recognizes epitope containing nucleic acid coupled to active protein; hybridomas
12/23/2004	US20040259805 Stimulant of milk ejection; contraction; stability
12/23/2004	US20040259795 Reducing sepsis; binding polypeptide to monoclonal antibody ; intensify gene expression; wound healing agents
12/23/2004	US20040259781 Drug screening ; polypeptide interfers with binding of fibronectin to; anticancer agents; antihistamines, antiarthritic agents, autoimmune disease, wound healing agents
12/23/2004	US20040259777 Method of treating metabolic disorders using neuronatin polypeptides
12/23/2004	US20040259771 Contacting mammals cells with ligand; binding; prevent activation; hybridomas cell line; respiratory system disorders; antiarthritic agents ; antiischemic agents
12/23/2004	US20040259220 CLK protein kinases and related products and methods
12/23/2004	US20040259210 Which encode bacteriophage signal peptides; for secretion of antibodies and/or fragment antigen binding fragments; cassettes; host cells
12/23/2004	US20040259198 Methionine adenosyltransferase II (MAT II); hybridoma cell lines; transgenic animals; assay kits
12/23/2004	US20040259196 T cell receptor variants expressed in mesenchymal cells and uses thereof
12/23/2004	US20040259174 designated SM047, as diagnostic aid; test kits; hybridomas that make said antibody
12/23/2004	US20040259171 P2Y4 antibody and methods of use
12/23/2004	US20040259167 Isolated osteocalcin fragments
12/23/2004	US20040259156 Bispecific immunoglobulin-like antigen binding proteins and method of production
12/23/2004	US20040259153 binding an affinity linker to a target, contacting with a replicable genetic display package (rgdp) library to bind the target substance, binding the affinity linker with a binding partner to recover the binding molecule; identifying antibodies to target antigens such as influenza virus HA protein
12/23/2004	US20040259150 Method of enhancing of binding activity of antibody composition to Fcgamma receptor IIIa
12/23/2004	US20040259139 Novel proteins in enteroaggregative escherichia coli (EAEC) useful for diagnosis and therapy of EAEC infections
12/23/2004	US20040259126 MN gene and protein
12/23/2004	US20040259114 Coactivators in the diagnosis and treatment of breast cancer
12/23/2004	US20040259113 by determining the presence of kallikrein protein, hK2 polypeptide of hK2 RNA in a physiological sample
12/23/2004	US20040259110 Gene PRV-1 and its use
12/23/2004	US20040259092 Nogo receptor homologues and their use
12/23/2004	US20040259077 Administering antibodies, heavy/light chains, and FAB fragments to treat anaphylactic hypersensitivity, bee stings, snake bites, asthma, allergic rhinitis, eczema, urticaria and food allergies; point mutations
12/23/2004	US20040259075 For blocking entry into cells and inhibiting replication; chemokine receptors
12/23/2004	US20040258713 Attenuated mutant newcastle disease virus strains for in ovo vaccination, method for preparing and their use
12/23/2004	US20040258709 Hepatitis B virus polypeptides
12/23/2004	US20040258699 Treating an animal infected with Bacillus anthracis by administering an antibody or antibody fragment having binding affinity to the protective antigen of Bacillus anthracis and the ability to block binding of the protective antigen to cell receptors, edema factor and lethal factor; vaccines
12/23/2004	US20040258697 Methods of using multivalent MHC class II-peptide chimeras
12/23/2004	US20040258696 Compositions and methods for the diagnosis and treatment of tumor
12/23/2004	US20040258695 Transferrin binding peptides and uses thereof
12/23/2004	US20040258693 Customization of cancer therapy by adminstering modifying antibodies from antigens expressed from cancerous tissue which are cytotoxic to cancer cells while non-toxic to non-cancerous cells; monoclonal antibody antigen binding fragment having identifying characteristics to deposit PTA-4890 at the ATCC
12/23/2004	US20040258692 Method for the treatment of cardiotoxicity induced by antitumor compounds
12/23/2004	US20040258691 Treating psoriasis in a patient by administering a therapeutically effective amount of an antibody immunospecific for vetronectin receptor av beta 3; antiinflammatory agents; antibody does not immunoreact with integrins other than av beta 3; cell adhesion
12/23/2004	US20040258689 Augmenting activin induced signaling in cells; screening for complex inhibitors; treatment of reproductive, developmental, skin, bone, hepatic, hematopoietic and/or central nervous system disorders; prostrate cancer
12/23/2004	US20040258686 Mammalian receptor proteins; related reagents and methods
12/23/2004	US20040258685 Blocking ligand activation of epidermal growth factor receptor; psoriasis, endometriosis, scleroderma, vascular disorders, respiratory disease, colon polyps
12/23/2004	US20040258684 Agonist antibodies
12/23/2004	US20040258682 Monoclonal antibody or fragment engineered in non-Fc constant heavy or light region; immunoconjugates for cancer diagnosis and therapy
12/23/2004	US20040258680 Methos of healing or preventing inflammation, damage and other changes that occur prior to, during or immediately after a myocardial event with thymosin beta 4, analogoues, isoforms and other derivatives
12/23/2004	US20040258678 Isolated nucleic acid having high identity to sequence 215; vectors, host cells, antibodies

1 ... 779 780 781 782 783 784 785 786 787 788 789 790 791 792 793 794 795 796 797 798 799 ... 1494